No insider purchase over the last 90 days. The latest, by Fruholmen Invest AB, was filed 19 Dec 2019.
Senzime is a listed company. Its directors and officers file their transactions with Finansinspektionen. No insider at Senzime has published a filing in the past twelve months. The most recent one dates from 20 November 2020.
Our records for Senzime go back to 2016, with 18 purchases and 2 sales on the open market in total.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
20 of 20 declarations
Senzime is a Swedish company focused on developing patient monitoring solutions. It aims to enhance healthcare through innovative technologies.
Purchases our model currently ranks for the recommendations list.
All recommendations